Media Thread, page-15219

Hi Col,
the video was released January 11th 2020 by Precision BioSciences to explain CAR T with the following preview -

"What do frozen samurai warriors and magic goggles have to do with treating cancer?
Join Derek Jantz, Chief Science Officer at Precision BioSciences, on a journey into the
future of cancer therapies, and learn how ARCUS—Precision's new genome editing
technology—is used to make off-the-shelf, donor-derived CAR T cell therapies with
the potential to change the way the world battles cancer."

Looks like Imugene has simply rebranded it as their own




Personally, I do not care for the SP,
I am very comfortable with the future of this stock.

Understand the science,
appreciate the investment cycle
and listen to the scientist

"so we think we have actually designed a virus that only infects cancer
and so those things that we've seen in the laboratory and in animal studies
it's just been quite remarkable to see a lot of them in humans as we go forward
in testing so I thank Leslie and Imugene for taking the product forward and
doing these trials so quickly but what we've seen in Bile duct cancer has been
quite surprising to me and pleasantly surprising to me.
This is the disease that I've treated for 40 years when somebody has stage four
disease widespread disease usually their life span is in months and usually
chemotherapy and radiation doesn't work and in our trial you actually have to
have failed chemotherapy to enter and to have a patient that actually now
is disease free all that the cancer is gone and without treatment for now
over a year and still disease free.
And then the second patient with a disease basically has frozen in its tracks and not
grown and ... it's something that I have not seen before with any other therapy
so quite exciting and very happy to move forward with this"

Professor Yuman Fong (Just Stocks 17th July 2024)




GLTAH - Go Team Imugene

.